Y-mAbs Therapeutics Inc (YMAB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

750 THIRD AVENUE NEW YORK, NY 10017

Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including one FDA approved product, DANYELZA® (naxitamab-gqgk), which targets tumors that express GD2, and one pivotal-stage product candidate, omburtamab, which targets tumors that express B7-H3.

Data as of 2021-08-02 09:03:00 -0400
Market Cap1.442 Billion Shares Outstanding43.571 Million Avg 30-day Volume196.537 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE2.64 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.2597 52-week High/Low55.22 / 24.78 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) 44.0381
Data provided by IEX Cloud
View SEC Filings from YMAB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 117 114 2.63% 39 (2.29%) 33 (1.92%) 18.18%
13F shares: 26.472 Million 22.459 Million 17.87% 15.057 Million 12.462 Million 20.82%
% Ownership 60.8196 55.4352 9.71% 34.5923 30.7608 12.46%
New Positions: 18 14 28.57% 8 4 100.0%
Increased Positions 54 47 14.89% 19 15 26.67%
Closed Positions 14 6 133.33% 2 3 -33.33%
Reduced Positions 32 34 -5.88% 10 11 -9.09%
Total Calls
Total Puts 16.004 Thousand
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding YMAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding YMAB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

503.3 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KRUSE BO EVP, CFO, SECRETARY & TREAS.

  • Officer
233,077 2021-08-04 7

GAD THOMAS SEE REMARKS

  • Officer
  • Director
1,583,927 2021-08-03 32

GILL DAVID N

  • Director
16,000 2021-06-10 4

WG BIOTECH APS

  • Director
  • SEE REMARKS
4,178,456 2021-06-10 5

WEDELL-WEDELLSBORG JOHAN

  • Director
16,000 2021-06-10 7

TYAGI ASHU

  • Director
16,000 2021-06-10 1

BER GERARD

  • Director
16,000 2021-06-10 1

HAMILL LAURA

  • Director
16,000 2021-06-10 1

WILMS JORIS SVP & CCO

  • Officer
0 2020-12-15 1

LUND-HANSEN TORBEN SVP & CTO

  • Officer
0 2020-12-15 1

LISBY STEEN SVP & CSO

  • Officer
0 2020-12-15 1

MOLLER-SAN PEDRO CLAUS JUAN DIRECTOR AND CEO

  • Officer
  • Director
0 2020-12-15 2

HERMAN PHILIP KARL SVP & CCO

  • Officer
0 2020-12-15 1

RAJAH VIGNESH SVP & CMO

  • Officer
0 2020-12-15 2

HEALY JAMES

  • Director
0 2020-06-23 0

AHMED MAHIUDDIN SR. VP AND CSO

  • Officer
150,000 2020-05-26 0

RASKIN GREGORY S

  • Director
0 2019-08-29 0

BUSCHLE MICHAEL

  • Director
0 2018-09-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KRUSE BO - Officer EVP, CFO, SECRETARY & TREAS.

2021-08-05 17:20:59 -0400 2021-08-04 S 4,000 $33.72 d 233,077 direct yes

GAD THOMAS - Director - Officer SEE REMARKS by gad enterprises llc

2021-08-05 17:18:56 -0400 2021-08-03 S 4,000 $33.73 d 1,583,927 indirect yes

KRUSE BO - Officer EVP, CFO, SECRETARY & TREAS.

2021-07-26 06:19:11 -0400 2021-07-22 S 4,000 $34.50 d 237,077 direct yes -0.8555 4.7968 4.7968 6 -0.8555 2

GAD THOMAS - Director - Officer SEE REMARKS by gad enterprises llc

2021-07-21 18:56:36 -0400 2021-07-20 S 4,000 $32.47 d 1,587,927 indirect yes 1.9625 -3.3189 1.9625 2 -6.3492 4

GAD THOMAS - Director - Officer SEE REMARKS by gad enterprises llc

2021-07-08 17:16:17 -0400 2021-07-07 S 4,000 $31.87 d 1,591,927 indirect yes -0.3339 -3.8859 0.0 1 -6.7092 4

KRUSE BO - Officer EVP, CFO, SECRETARY & TREAS.

2021-07-07 18:00:13 -0400 2021-07-06 S 4,000 $34.15 d 241,077 direct yes 4.1746 -1.4231 4.1746 2 -2.8147 5

GAD THOMAS - Director - Officer SEE REMARKS by gad enterprises llc

2021-07-02 16:31:09 -0400 2021-06-30 S 4,000 $33.86 d 1,595,927 indirect yes -2.0878 -2.1799 1.136 4 -2.9168 3

KRUSE BO - Officer EVP, CFO, SECRETARY & TREAS.

2021-06-23 16:30:42 -0400 2021-06-22 S 4,000 $36.17 d 245,077 direct yes -0.3483 1.9739 1.9739 6 -2.119 3

GAD THOMAS - Director - Officer SEE REMARKS by gad enterprises llc

2021-06-15 17:06:32 -0400 2021-06-14 S 4,000 $35.80 d 1,599,927 indirect yes 5.1984 -4.3879 -6.3723 5.1984 2 -14.114 20

HAMILL LAURA - Director

2021-06-14 17:06:15 -0400 2021-06-10 A 16,000 a 16,000 direct

WEDELL-WEDELLSBORG JOHAN - Director

2021-06-14 17:05:13 -0400 2021-06-10 A 16,000 a 16,000 direct

TYAGI ASHU - Director

2021-06-14 17:02:25 -0400 2021-06-10 A 16,000 a 16,000 direct

BER GERARD - Director

2021-06-14 17:03:48 -0400 2021-06-10 A 16,000 a 16,000 direct

WG BIOTECH APS - Director SEE REMARKS

2021-06-11 17:01:10 -0400 2021-06-10 S 11,229 $36.15 d 4,178,456 direct -4.9216 1.0448 -10.7781 3.4919 4 -15.5073 22

GILL DAVID N - Director

2021-06-14 17:03:07 -0400 2021-06-10 A 16,000 a 16,000 direct

HEALY JAMES - Director

2021-06-14 17:04:34 -0400 2021-06-10 A 16,000 a 16,000 direct

WEDELL-WEDELLSBORG JOHAN - Director by wg biotech aps

2021-06-11 17:00:45 -0400 2021-06-10 S 11,229 $36.15 d 4,178,465 indirect -4.9216 1.0448 -10.7781 3.4919 4 -15.5073 22

WG BIOTECH APS - Director SEE REMARKS

2021-06-10 19:00:53 -0400 2021-06-09 S 116,700 $36.19 d 4,189,694 direct 0.2204 -0.1929 -9.8099 3.72 5 -15.321 23

WEDELL-WEDELLSBORG JOHAN - Director by wg biotech aps

2021-06-10 18:35:29 -0400 2021-06-09 S 116,700 $36.19 d 4,189,694 indirect 0.2204 -0.1929 -9.8099 3.72 5 -15.321 23

WEDELL-WEDELLSBORG JOHAN - Director by wg biotech aps

2021-06-10 18:35:29 -0400 2021-06-08 S 33,300 $35.28 d 4,306,394 indirect 0.2204 -0.1929 -9.8099 3.72 5 -15.321 23

WG BIOTECH APS - Director SEE REMARKS

2021-06-10 19:00:53 -0400 2021-06-08 S 33,300 $35.28 d 4,306,394 direct 0.2204 -0.1929 -9.8099 3.72 5 -15.321 23

WEDELL-WEDELLSBORG JOHAN - Director by wg biotech aps

2021-06-09 18:49:27 -0400 2021-06-07 S 72,400 $34.15 d 4,339,694 indirect -3.304 0.2931 -5.862 0.2931 6 -18.1188 24

WG BIOTECH APS - > 10% Owner

2021-06-09 18:51:22 -0400 2021-06-07 S 72,400 $34.15 d 4,339,694 direct -3.304 0.2931 -5.862 0.2931 6 -18.1188 24

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 22:15:04 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 21:45:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 21:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 20:45:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 20:15:04 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 19:45:04 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 19:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 18:45:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 18:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 17:45:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 17:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 16:45:02 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 16:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 15:45:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 15:15:02 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 14:45:02 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 14:15:04 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 13:45:04 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 13:15:03 UTC -0.6617 0.7417 95000
Y-MABS THERAPEUTICS INC YMAB 2021-08-05 12:45:03 UTC -0.6617 0.7417 95000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Market Neutral Fund YMAB -1607.0 shares, $-69149.21 2020-08-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund YMAB -66.0 shares, $-1722.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund YMAB -69.0 shares, $-1800.9 2020-03-31 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio YMAB -5300.0 shares, $-160272.0 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio YMAB -4600.0 shares, $-139104.0 2021-03-31 N-PORT

Elevate your investments